Targeted degradation of a constitutively active GPCR oncoprotein
Open Access
Abstract
No abstract availableFunding Information
- Pharmaceutical Research and Manufacturers of America Foundation
- Robertson Foundation
- National Institute of General Medical Sciences
This publication has 58 references indexed in Scilit:
- BRAFV600E‐PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterizationClinical and Translational Medicine, 2025
- Next steps for targeted protein degradationCell Chemical Biology, 2024
- Application of bioluminescence resonance energy transfer to quantitate cell-surface expression of membrane proteinsAnalytical Biochemistry, 2023
- Genetic code expansion to enable site‐specific bioorthogonal labeling of functional G protein‐coupled receptors in live cellsProtein Science, 2023
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands, New Drug Leads and PROTACsAngewandte Chemie International Edition, 2022
- First small-molecule PROTACs for G protein-coupled receptors: inducing 1A-adrenergic receptor degradationActa Pharmaceutica Sinica B, 2020
- Targeted Degradation of SLC Transporters Reveals Amenability of Multi-Pass Transmembrane Proteins to Ligand-Induced ProteolysisCell Chemical Biology, 2020
- Optimizing fluorescent protein expression for quantitative fluorescence microscopy and spectroscopy using herpes simplex thymidine kinase promoter sequencesFEBS Open Bio, 2018
- Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cellsThe Prostate, 2010
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomicsBioorganic & Medicinal Chemistry Letters, 2008